call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
India In Vitro Diagnostics Market
Inquire Before Buying Request for Sample

India In Vitro Diagnostics Market

Home Healthcare And Pharmaceutical India In Vitro Diagnostics Market

India In-Vitro Diagnostics (IVD) Market, By Product and Services (Reagents and Kits, Instruments, Software and Services); By Technique (Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology); By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases); By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

  • Published Date: September 2024
  • Report ID: BWC24657
  • Available Format: PDF
  • Page: 130

Report Overview

Increasing prevalence of chronic diseases, innovations in IVD technology, such as point-of-care testing, molecular diagnostics, and automation, rising healthcare expenditure, and growing awareness about early disease detection are expected to drive India In-Vitro Diagnostics (IVD) Market during the forecast period between 2024 and 2030

India In-Vitro Diagnostics (IVD) Market – Industry Trends & Forecast Report, 2030

India In-Vitro Diagnostics (IVD) Market size was estimated at USD 1.69 billion in 2023. During the forecast period between 2024 and 2030, India In-Vitro Diagnostics (IVD) Market size is projected to grow at a CAGR of 6.25% reaching a value of USD 2.56 billion by 2030. Prominent drivers of the market include the increasing demand for infectious disease testing, the rising prevalence of chronic diseases, and a strong network of laboratories across the country. Government initiatives, such as the “Make in India” program, are further enhancing the domestic production of medical devices, meeting the growing need for diagnostic solutions. The COVID-19 pandemic significantly boosted market expansion, alongside an increase in infectious diseases like HIV/AIDS, tuberculosis, and hospital-acquired infections. Additionally, the growing geriatric population and the need for accurate diagnostic tests for chronic conditions continue to drive demand. Companies are also leveraging government-backed initiatives and mergers to enhance market presence. Cipla, for example, launched the RT-Direct multiplex COVID-19 RT-PCR Test in collaboration with Genes2Me, while Fujirebio partnered with Agappe to manufacture CLIA reagents. Regulatory support, including the DCGI's fast-track approval process, is attracting global players to the Indian market. IVD tests, such as immunodiagnostics, molecular diagnostics, and clinical chemistry, are vital for early disease detection, helping to guide personalized treatments and improve healthcare outcomes.

India In-Vitro Diagnostics Market

In-Vitro Diagnostics (IVD) – Overview

In-Vitro Diagnostics (IVD) refers to medical tests and procedures performed on samples such as blood, urine, or tissue that are taken from the human body. These tests are conducted outside the body, typically in a laboratory setting, to detect diseases, conditions, or infections. IVD tests are used for diagnosing diseases, monitoring health conditions, and guiding treatment decisions. Common examples include blood glucose tests, pregnancy tests, and tests for infectious diseases. IVD devices range from simple test kits to complex laboratory instruments and are crucial in preventive healthcare, diagnosis, and disease management.

India In-Vitro Diagnostics (IVD) Market

Growth Drivers

Innovations in IVD Technology

Innovations in IVD technology, including point-of-care testing, molecular diagnostics, and automation, are significantly propelling the growth of India’s In-Vitro Diagnostics (IVD) industry. Advancements in molecular diagnostics and next-generation sequencing are paving the way for more accurate and personalized medical diagnoses, detecting diseases at the molecular level. The rise of point-of-care (POC) testing, which delivers quick results at the patient’s location, is revolutionizing diagnostics, especially in rural regions with limited healthcare access. Automation in diagnostic processes is also improving efficiency, accuracy, and accessibility. Government initiatives like ‘Make in India’ and ‘Atmanirbhar Bharat’ are encouraging the domestic production of advanced diagnostic tools, reducing reliance on imports, and making diagnostics more affordable. While challenges such as market fragmentation and regulatory hurdles remain, continued innovation, supported by collaborations with global firms and research institutions, is set to drive further expansion of India’s IVD industry.

Challenges

High Cost of Development

The high cost of development poses a significant restraint on the growth of the India In-Vitro Diagnostics (IVD) market. Developing advanced diagnostic tools, including molecular diagnostics and point-of-care testing, requires substantial investment in research, technology, and skilled personnel. This results in higher production costs, which can lead to increased prices for diagnostic tests, limiting accessibility for a large segment of the population. Additionally, the costs associated with regulatory approvals, compliance with stringent standards, and local manufacturing further exacerbate the financial burden on IVD companies, hindering the overall growth of the market.

Impact of Escalating Geopolitical Tensions on India In-Vitro Diagnostics (IVD) Market

Escalating geopolitical tensions among countries across regions could have a significant impact on the growth of India In-Vitro Diagnostics (IVD) Market. Such tensions often disrupt global supply chains, leading to shortages of essential raw materials and components used in diagnostic devices. Trade restrictions and sanctions can further increase costs and delay the import of advanced technologies, affecting market stability. Additionally, geopolitical uncertainties can deter foreign investments and collaborations, limiting opportunities for innovation and growth in the IVD sector. As geopolitical conflicts continue to evolve, the Indian IVD market faces challenges in maintaining consistent supply, controlling costs, and sustaining overall growth.

India In-Vitro Diagnostics (IVD) Market

Segmental Coverage

India In-Vitro Diagnostics (IVD) Market – By Product and Services

By product and services, India In-Vitro Diagnostics (IVD) Market is divided into Reagents and Kits, Instruments, and Software and Services segments. The reagents and kits segment holds the highest share in India In-Vitro Diagnostics (IVD) Market by product and services, due to the extensive use of IVD testing, rising demand for self-testing and point-of-care products, and heightened R&D efforts. Additionally, the introduction of new reagents is expected to propel market expansion. The increased frequency of tests during the COVID-19 pandemic has driven up production of testing kits, thereby boosting demand for IVD products. For example, in May 2022, Cipla Limited launched the 'RT-Direct' multiplex COVID-19 RT-PCR Test kit in India in collaboration with Genes2Me Pvt. Ltd., with validation from the Indian Council of Medical Research (ICMR).

India In-Vitro Diagnostics Market Size

India In-Vitro Diagnostics (IVD) Market – By Technique

Based on technique, India In-Vitro Diagnostics (IVD) Market is divided into Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, and Hematology segments.

India In-Vitro Diagnostics (IVD) Market – By Application

Based on application, India In-Vitro Diagnostics (IVD) Market is divided into Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, and Gastrointestinal Diseases segments. The infectious diseases segment holds the highest share in India In-Vitro Diagnostics (IVD) Market by application, driven by the impact of COVID-19. To enhance access to advanced laboratory services, key players are launching innovative testing products. For example, in February 2023, Thermo Fisher partnered with Mylab to introduce RT-PCR kits for detecting various infectious diseases, including multi-drug-resistant tuberculosis (MTB MDR), Hepatitis B (HBV), Hepatitis C (HCV), and HIV, as well as for genetic analysis (HLA B27), with approval from the Central Drugs Standard Control Organization.

India In-Vitro Diagnostics (IVD) Market – By End User

By end user, India In-Vitro Diagnostics (IVD) Market is divided into Standalone Laboratories, Hospitals, Academic and Medical Schools, and Point of Care segments. The hospitals segment holds the highest share in India In-Vitro Diagnostics (IVD) Market by end user, driven by the increased need for early diagnostic support due to higher hospitalization rates. Additionally, ongoing economic development and supportive government initiatives are expected to improve hospital facilities, further boosting the demand for hospital-based IVD tests.

India In-Vitro Diagnostics (IVD) Market – By Region

The in-depth research report on India In-Vitro Diagnostics (IVD) Market covers the market in the country’s major regions: North India, South India, East India, and West India regions. North India holds the highest share in India In-Vitro Diagnostics (IVD) Market and is expected to maintain its dominance during the forecast period, due to its high population density and advanced healthcare infrastructure. The region, encompassing densely populated states such as Uttar Pradesh, Bihar, and Haryana, offers a substantial patient and consumer base for IVD products. The National Capital Region (NCR), including major cities like Delhi, Gurugram, and Noida, benefits from a well-developed network of hospitals, clinics, and diagnostic labs. This robust healthcare infrastructure, coupled with significant economic activity and increased healthcare spending in urban and semi-urban areas, bolsters North India's dominant position in the IVD market.

Competitive Landscape

Major players operating in India In-Vitro Diagnostics (IVD) Market include Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Becton and Dickinson, Sysmex, Transasia Bio-Medicals Ltd, Thermo Fisher Scientific Inc, J Mitra & Co Pvt Ltd, Advatech Healthcare Pvt Ltd, Tulip Diagnostics Pvt Ltd, Siemens Healthcare Pvt Ltd, and Bio-Rad Laboratories India Pvt Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In March 2024 - Medical Fair India 2024, held in Mumbai from March 13 to 15, Fapon, a leading life sciences company, showcased its advanced IVD technologies and solutions. The event allowed Fapon to present its latest innovations, including new biomarkers, reagents, and instrument platforms, designed to meet the evolving needs of the Indian healthcare industry.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2030

Base Year – 2023

Estimated Year – 2024

Forecast Period – 2024–2030

Facts Covered

USD Billion

Market Coverage

India 

Product/ Service Segmentation

Product and Services, Technique, Application, End User, Region

Key Players

Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Becton and Dickinson, Sysmex, Transasia Bio-Medicals Ltd, Thermo Fisher Scientific Inc, J Mitra & Co Pvt Ltd, Advatech Healthcare Pvt Ltd, Tulip Diagnostics Pvt Ltd, Siemens Healthcare Pvt Ltd, Bio-Rad Laboratories India Pvt Ltd

 

By Product and Services

  • Reagents and Kits

  • Instruments

  • Software and Services

By Technique

  • Molecular Diagnostics

  • Tissue Diagnostics

  • Clinical Chemistry

  • Immunodiagnostics

  • Hematology

By Application

  • Infectious Diseases

  • Cancer

  • Cardiac Diseases

  • Immune System Disorders

  • Nephrological Diseases

  • Gastrointestinal Diseases

By End User

  • Standalone Laboratories

  • Hospitals

  • Academic and Medical Schools

  • Point of Care

By Region

  • North India

  • South India

  • East India

  • West India

  1. Research Framework       
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. India In-Vitro Diagnostics (IVD) Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of chronic diseases
        2. Innovations in IVD technology, such as point-of-care testing, molecular diagnostics, and automation
        3. Rising healthcare expenditure
        4. Growing awareness about early disease detection
      2. Restraints
        1. Unfavorable reimbursement scenario
        2. High cost of development
        3. Stringent regulatory environment
      3. Opportunities
        1. Emerging technologies such as liquid biopsy, digital pathology, and microfluidics
        2. Increasing adoption of personalized medicine
        3. Growing demand for rapid and accessible diagnostic solutions
      4. Challenges
        1. Shortage of skilled professionals in the IVD industry
        2. Increasing concerns about data privacy and security
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. India In-Vitro Diagnostics (IVD) Market: Marketing Strategies
  5. India In-Vitro Diagnostics (IVD) Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product and Services
        1. Reagents and Kits
        2. Instruments
        3. Software and Services
      2. By Technique
        1. Molecular Diagnostics
        2. Tissue Diagnostics
        3. Clinical Chemistry
        4. Immunodiagnostics
        5. Hematology
      3. By Application
        1. Infectious Diseases
        2. Cancer
        3. Cardiac Diseases
        4. Immune System Disorders
        5. Nephrological Diseases
        6. Gastrointestinal Diseases
        7. Others
      4. By End User
        1. Standalone Laboratories
        2. Hospitals
        3. Academic and Medical Schools
        4. Point of Care
        5. Others
      5. By Region
        1. North India
        2. South India
        3. East India
        4. West India
  6. North India In-Vitro Diagnostics (IVD) Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product and Services
      2. By Technique
      3. By Application
      4. By End User
  7. South India In-Vitro Diagnostics (IVD) Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product and Services
      2. By Technique
      3. By Application
      4. By End User
  8. East India In-Vitro Diagnostics (IVD) Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product and Services
      2. By Technique
      3. By Application
      4. By End User
  9. West India In-Vitro Diagnostics (IVD) Market
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product and Services
      2. By Technique
      3. By Application
      4. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. India In-Vitro Diagnostics (IVD) Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Escalating Geopolitical Tensions on India In-Vitro Diagnostics (IVD) Market
  12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Roche Diagnostic
    2. Abbott Laboratories
    3. Beckman Coulter
    4. Becton and Dickinson
    5. Sysmex
    6. Transasia Bio-Medicals Ltd
    7. Thermo Fisher Scientific Inc
    8. J Mitra & Co Pvt Ltd
    9. Advatech Healthcare Pvt Ltd
    10. Tulip Diagnostics Pvt. Ltd.
    11. Siemens Healthcare Pvt. Ltd.
    12. Bio-Rad Laboratories India Pvt. Ltd
    13. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

 

*Financial information of non–listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in–depth secondary research for the final deliverable.

 

List of Figures

 

Figure 1       India In-Vitro Diagnostics (IVD) Segmentation

Figure 2       India In-Vitro Diagnostics (IVD) Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Figure 5       India In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value, 2019–2030

Figure 6       India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Figure 7       India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Figure 8       India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Figure 9       North India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Figure 10     North India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Figure 11     North India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Figure 12     North India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Figure 13     North India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Figure 14     South India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Figure 15     South India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Figure 16     South India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Figure 17     South India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Figure 18     South India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Figure 19     East India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Figure 20     East India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Figure 21     East India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Figure 22     East India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Figure 23     East India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Figure 24     West India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Figure 25     West India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Figure 26     West India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Figure 27     West India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Figure 28     West India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

 

 

List of Tables

 

Table 1        India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Table 2        India In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value, 2019–2030

Table 3        India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Table 4        India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Table 5        India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Table 6        North India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Table 7        North India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Table 8        North India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Table 9        North India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Table 10      North India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Table 11      South India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Table 12      South India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Table 13      South India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Table 14      South India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Table 15      South India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Table 16      East India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Table 17      East India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Table 18      East India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Table 19      East India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Table 20      East India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Table 21      West India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019–2030

Table 22      West India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019–2030

Table 23      West India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019–2030

Table 24      West India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019–2030

Table 25      West India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019–2030

Table 26      Roche Diagnostic Company Overview

Table 27      Roche Diagnostic Financial Overview

Table 28      Abbott Laboratories Company Overview

Table 29      Abbott Laboratories Financial Overview

Table 30      Beckman Coulter Company Overview

Table 31      Beckman Coulter Financial Overview

Table 32      Becton and Dickinson Company Overview

Table 33      Becton and Dickinson Financial Overview

Table 34      Sysmex Company Overview

Table 35      Sysmex Financial Overview

Table 36      Transasia Bio-Medicals Ltd Company Overview

Table 37      Transasia Bio-Medicals Ltd Financial Overview

Table 38      Thermo Fisher Scientific Inc Company Overview

Table 39      Thermo Fisher Scientific Inc Financial Overview

Table 40      J Mitra & Co Pvt Ltd Company Overview

Table 41      J Mitra & Co Pvt Ltd Financial Overview

Table 42      Advatech Healthcare Pvt Ltd Company Overview

Table 43      Advatech Healthcare Pvt Ltd Financial Overview

Table 44      Tulip Diagnostics Pvt. Ltd. Company Overview

Table 45      Tulip Diagnostics Pvt. Ltd. Financial Overview

Table 46      Siemens Healthcare Pvt. Ltd. Company Overview

Table 47      Siemens Healthcare Pvt. Ltd. Financial Overview

Table 48      Bio-Rad Laboratories India Pvt. Ltd Company Overview

Table 49      Bio-Rad Laboratories India Pvt. Ltd Financial Overview

Table 50      Other Prominent Players Company Overview

Table 51      Other Prominent Players Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: India In-Vitro Diagnostics (IVD) Market size by value was estimated at USD 1.69 billion.
Ans: India In-Vitro Diagnostics (IVD) Market is expected to grow at CAGR of 6.25% during the forecast period between 2024 and 2030.
Ans: By 2030, India In-Vitro Diagnostics (IVD) Market size is forecast to reach a value of USD 2.56 billion.
Ans: The growth of India In-Vitro Diagnostics (IVD) Market is primarily driven by an increasing prevalence of chronic diseases, innovations in IVD technology, such as point-of-care testing, molecular diagnostics, and automation, rising healthcare expenditure, and growing awareness about early disease detection.
Ans: The hospitals segment is expected to grow at the fastest CAGR in India In-Vitro Diagnostics (IVD) Market during the forecast period between 2024 and 2030.
Ans: Key players in India In-Vitro Diagnostics (IVD) Market include Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Becton and Dickinson, Sysmex, Transasia Bio-Medicals Ltd, Thermo Fisher Scientific Inc, J Mitra & Co Pvt Ltd, Advatech Healthcare Pvt Ltd, Tulip Diagnostics Pvt Ltd, Siemens Healthcare Pvt Ltd, and Bio-Rad Laboratories India Pvt Ltd.